Atlas Trials

Efficacy and Safety of Icaritin Combined With mFOLFOX in Postoperative HCC With High-risk Recurrence Factors

Clinical trial NCT07337460 · RECRUITING

Trial details

NCT number
NCT07337460
Sponsor
Northern Jiangsu People's Hospital
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Hepatocellular Carcinoma (HCC)
Start date
2025-11-01
Primary completion
2027-11-30
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.